CADL vs MS · $592.0M cap vs P/E 20, rev $41.93B
Candel Therapeutics Inc (CADL) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
CADL does not have a complete income-statement cache yet.
Latest reported MS revenue for 2026-06-30 was $41.93B. Net income was $11.15B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
CADL currently screens at market cap $592.0M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the CADL and MS stock pages for the full models.
Not investment advice.